Norden Gregory 4
4 · Praxis Precision Medicines, Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Praxis (PRAX) Director Norden Receives RSU & Derivative Award
What Happened
Gregory Norden, a director of Praxis Precision Medicines (PRAX), was awarded two equity grants on June 10, 2026: 1,371 restricted stock units (RSUs) and 648 derivative awards. Both grants were reported at $0.00 (i.e., no cash purchase). The RSUs convert into common shares and vest in a single installment on the earlier of June 10, 2027 or the company’s 2027 annual meeting. The 648-share derivative award vests in 12 equal monthly installments beginning July 10, 2026 and finishing on the earlier of June 10, 2027 or the 2027 annual meeting.
Key Details
- Transaction date: June 10, 2026; Form 4 filed June 12, 2026 (timely filing).
- Consideration: $0.00 per share (awards/grants, not purchases).
- Awards: 1,371 RSUs (settled only in shares) and 648 derivative shares (monthly vesting).
- Vesting: RSUs vest in one installment by June 10, 2027 (or at 2027 annual meeting); derivative vests monthly from July 10, 2026 through June 10, 2027 (or earlier at the 2027 annual meeting).
- Shares owned after transaction: not specified in the filing.
- Footnotes: RSUs are payable only in common stock and are reported in Table 1 per SEC guidance.
Context
These are grants/awards to a director (compensation/retention), not open‑market purchases or sales, so they do not by themselves signal buying or selling intent. RSUs and similar derivative awards are common for board compensation; they vest over time and will convert to actual shares only if vesting conditions are met.
Insider Transaction Report
- Award
Common Stock
[F1]2026-06-10+1,371→ 1,559 total - Award
Stock Option (Right to Buy)
[F2]2026-06-10+648→ 648 totalExercise: $240.66Exp: 2036-06-10→ Common Stock (648 underlying)
Footnotes (2)
- [F1]Mr. Norden was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.